Skip to main content

PHYSIOLOGICAL AND ECOLOGICAL IMPACT OF PRE- AND PROBIOTIC INTERVENTIONS IN RELATION TO FOOD ALLERGY IN EARLY-LIFE.

PCI2021-122059-2A

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Afrontar las Prioridades de Nuestro Entorno
Subprogram Subprograma Estatal de Internacionalización
Call Proyectos Programación Conjunta Internacional
Call year 2021
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Role of vertical and horizontal microbial transmission of antimicrobial resistance genes in early life: insights from maternal-infant dyads

  • Bernabeu, Manuel
  • Cabello Yeves, Elena
  • Flores, Eduard
  • Samarra, Anna
  • Kimberley Summers, Joanna
  • Marina, Alberto
  • Collado, María Carmen
Early life represents a critical window for metabolic, cognitive and immune system development, which is influenced by the maternal microbiome as well as the infant gut microbiome. Antibiotic exposure, mode of delivery and breastfeeding practices modulate the gut microbiome and the reservoir of antibiotic resistance genes (ARGs). Vertical and horizontal microbial gene transfer during early life and the mechanisms behind these transfers are being uncovered. In this review, we aim to provide an overview of the current knowledge on the transfer of antibiotic resistance in the mother-infant dyad through vertical and horizontal transmission and to highlight the main gaps and challenges in this area., This work has been supported by PROMETEO GVA (NEOHEALTH ref. 2020/012). The authors acknowledge the comments and suggestions of Dr. Raul Cabrera-Rubio. who thanks the Generalitat-Valenciana for the grant of the Plan GenT project (CDEIGENT 2020). M.B. thanks to the post-PhD grant 'Juan de la Cierva' (ref. JDC2022-050269-I) supported by the Spanish Ministry of Science, Innovation and Universities/State Investigation Agency (MCIU/AEI) and the European Union 'NextGenerationEU'/PRTR. E.C-Y received a FPI predoctoral fellowship from the Spanish Ministry of Science and Innovation with identifier PRE2020-092531. E.F.V thanks to a Predoctoral grant awarded by the Spanish Ministry of Science and Innovation and the European Social Fund Plus (ESF+) for the training of doctors within the framework of the State Plan for Scientific, Technical and Innovation Research 2021–2023 (ref. CEX2021-001189-S-20-1). A.S. acknowledges Generalitat-Valenciana-European Social Fund (ACIF/2021) for the predoctoral fellowship grant. M.C.C. acknowledges the support by the European Research Council Starting grant (MAMI grant ref. 639226), Horizon Europe Program (INITIALISE ref. 101094099), Spanish Ministry of Science and Innovation (MAMI-Plus ref. PID2022-139475OB-I00), by the Joint Action 'European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI-HDHL)' — FOOD-HYPERSENS call (ECOBIOTIC) and the national funding from Programación Conjunta Internacional (PCI) (ref. PCI2021-122059-2A), Spanish Government (Ministry of Science, Innovation and Universities) and also by Biostime Institute Nutrition & Care (BINC) grant. IATA-CSIC authors also acknowledge the Spanish government Ministry of Science and Innovation/State Investigation Agency (MCIN/AEI) to the Center of Excellence Accreditation Severo Ochoa (CEX2021-001189-S/MCIN/AEI/10.13039/501100011033). A.M. acknowledges the support by grants PID2019-108541GB-I00 and PID2022-137201NB-I00 from Spanish Government (Ministry of Science and Innovation). M.C.C. and A.M. are part of the CSIC's Global Health Platform (PTI Salud Global)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

An Old Story Back: Human Milk Antibodies' Protective Roles Against Allergy Development

  • Jackson, Courtney M.
  • Collado, María Carmen
  • Dallas, David C.
  • Insel, Richard A.
  • Macpherson, Andrew J.
  • Palmer, Debra J.
  • Seppo, Antti E.
  • Verhasselt, Valerie
  • Järvinen, Kirsi M.
Human milk is a rich source of immunomodulatory factors that influence the development of the infant immune system, including susceptibility to allergic diseases. Among these components, milk antibodies have been extensively studied for their role in protecting against infections; however, their potential contribution to allergy prevention may be equally important. The mechanisms of protection include allergen exclusion, enhanced and targeted antigen presentation, immune modulation via shaping of the infant gut microbiome, and direct regulation of gut immune responses. This review summarizes current evidence on the secretion of human milk antibodies, highlights what is known and what remains unclear about their role in allergy prevention and outlines the need for further research to develop antibody-based strategies for early allergy prevention., his work was supported by H2020-ERC Starting Grant (MAMI, ref. 639226), Horizon Europe Program (INITIALISE, ref. 101094099), the Joint Action ‘European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI-HDHL)’—FOOD-HYPERSENS call (ECOBIOTIC), Programación Conjunta Internacional (PCI) (ref. PCI2021-122059-2A), Spanish Ministry of Science and Innovation (MCIN) research grant (MAMI+, ref. PID2022-139475OB-I00), NIH R01HD109193, R01HD097367 and R01HD106140, Family Larsson Rosenquist Foundation, Stan Perron Charitable Foundation Fellowship, National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Numbers U19AI175113 and U01AI173032., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Human Milk Bioactive Compounds and Allergic- and Infectious-Related Infant Outcomes: A Systematic Review

  • Flores Ventura, Eduard
  • Guseva, Daria
  • Hübert, Vanessa
  • Samarra, Anna
  • Ensenauer, Regina
  • Collado, María Carmen
The impact of Human Milk (HM) bioactive compounds on infant health is crucial yet complex. Current research highlights their role in immune system development and disease prevention. This review aims to synthesize existing literature on the role of HM's bioactive compounds in the onset of diagnosed allergies, immunological diseases, and responses to infectious diseases by infants and children up to 18 years. The systematic review adhered to Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA). A comprehensive search strategy was employed across PubMed, Web of Science, SCOPUS, Scientific Electronic Library Online (SciELO), Cochrane Library, Latin American and Caribbean Health Sciences Literature (LILACS), and LIVIVO. Quality assessment utilized Joanna Briggs Institute checklists for various study designs. Protocol: CRD42023432030. The systematic review encompassed 34 studies, published from 1983 to 2024, representing a total of 9,298 mother-infant dyads. Included studies reported that allergic-related conditions, particularly food allergy, sensitization, and atopic dermatitis, were inversely associated with HM linolenic and linoleic acid. In a meta-analysis of three studies, infants with atopic dermatitis showed lower total omega-3 levels (SMD = -0.46, 95% CI: -1.82 to -0.90, I2 = 91%, p < 0.01), with reduced EPA and DGLA, suggesting, but not confirming, a potential protective role of omega-3 and involvement of inflammatory pathways. Furthermore, results on infectious-related conditions, primarily diarrhoea and Group B Streptococcus (GBS) infections, suggested inverse associations with 2'-fucosyllactose (2´-FL), lacto-N-difucohexaose I (LDFH-I), and immunoglobulins (Anti-GBS secretory immunoglobulin A (SIgA), anti-lipopolysaccharide IgA (Anti-LPS IgA), anti-cholera toxin IgA, respectively). Results of studies on upper and lower respiratory tract infections, otitis media, and dental caries suggested inverse associations with galectins and galectin-3, lacto-N-tetraose (LNT), 2´-FL, and Haemophilus influenzae. Data suggest that HM bioactive compounds, such as polyunsaturated fatty acids (PUFAs), HMOs, and a number of specific immunoglobulin A (IgA) antibodies may influence allergic and infectious outcomes in infants. In pooled analyses of omega-3 levels, HM fed to infants with atopic dermatitis showed reduced EPA and DGLA. However, these pooled estimates are severely limited by high statistical heterogeneity (I2 = 91%) and should be interpreted as exploratory findings. Despite of the limited overall evidence due to heterogeneity, low replication, and methodological variability, this review offers a broad synthesis of current findings and highlights key knowledge gaps, providing a foundation for future research focused on elucidating the immunological roles of understudied components, such as antimicrobial peptides, through multi-omics and longitudinal approaches., E.F.V. was supported by a predoctoral grant awarded by the Spanish Ministry of Science and Innovation and the European Social Fund Plus (ESF+) for doctoral training within the framework of the State Plan for Scientific, Technical and Innovation Research 2021–2023 (ref. CEX2021-001189-S-20-1). E.F.V. and M.C.C. also acknowledge support from the Spanish Ministry of Science and Innovation (MAMI-Plus project, ref. PID2022-139475OB-I00), as well as from the Joint Action, “European Joint Programming Initiative: A Healthy Diet for a Healthy Life” (JPI-HDHL) FOOD-HYPERSENS call (ECOBIOTIC project, ref. MCIN/AEI/10.13039/501100011033 and the European Union ‘NextGenerationEU’/PRTR), and national funding from the Programación Conjunta Internacional (PCI) (ref. PCI2021-122059-2A) of the Spanish Ministry of Science, Innovation and Universities. The IATA-CSIC team acknowledges the award from the Spanish Government (MCIN/AEI) to the Institute of Agrochemistry and Food Technology (IATA-CSIC) as a Centre of Excellence Severo Ochoa (CEX2021-001189-S, MCIN/AEI/10.13039/501100011033), With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S)., Peer reviewed